Join over 2,000 investors and sign up to our platform to review and compare our latest opportunities. Please contact us for more information about upcoming opportunities or our technology.
Investments shown on this site put your capital at risk and should be considered by experienced investors only. Learn more
- £20,000Min. Investment
- EISFund Type
- EvergreenClosing Date
The Fund seeks to leverage Newable’s unique corporate infrastructure to invest in knowledge intensive companies at the point of commerialisation and once a company has proven the concept through early-stage revenues. The investments are supported by Newable's wider platform, providing serviced offices, advisory services, and lending solutions.
Newable also benefits from the expertise of circa 300 professionals, the Newable EIS Scale-Up Fund 3 has a unique eco-system from which to originate, undertake due diligence, execute, support, monitor and ultimately exit investments. The Fund aims to provide investors with a diversified portfolio of 7-10 knowledge intensive companies, offering investors exposure to an exciting asset class without the need to stock pick and commit management time.
Risk is mitigated through a selection methodology and due diligence built around Newable’s +300 strong investor group as well as by leveraging the Enterprise Investment Scheme for early stage investments.
- Newable can provide strong support at the scale-up growth stage, drawing on broader group resources across a range of disciplines including grant writing services, export services and innovation advice.
- Newable curates one of the most comprehensive and sophisticated deal flow eco-systems in early stage investing. This eco-system yields around 1,500 investment opportunities every year.
- The Newable Ventures Investment Advisory committee has over 110 years of combined investment experience with a track record of making successful investments across the Innovation and Technology space. Recent examples include:
- Atelerix: Invested Jan 2018 returning a 2.07x uplift in share price
- Cognism: Invested in March 2018 returning a 3.42x uplift in share price
- Hummingbird Technologies Invested in March 2018 returning a 2.25x uplift in share price
We offer investors access to the knowledge and investment skillset that we have developed by being technology sector focussed. The sectors in which we specialise provide particular opportunities created through the emergence of the fourth industrial revolution. This expertise, combined with the strong analytical skillset across our Investment Committee and Investor Network leads, we believe, to a competitive advantage for the Fund.
Specialist sectors include:
• Electronics: Hardware, Components & Firmware
• Automation: AI, Data Science, Cyber
• Healthcare: Digital Health, Genomics & Devices
• Space: Downstream Data Technologies
The Fund will target the funding gap that exists for companies which have potentially de-risked their technology, developed traction with customers and now seek funding to scale their commercial operations. The Fund aims to provide investors with a diversified portfolio of 7-10 qualifying companies per investment.
Preliminary investment profiling
Management team: High calibre, committed, track record of scaling and exiting businesses
Technical; significantly mitigated through product development and previous funding
Commercial: Evidence of revenue generation
Large addressable market in the UK and where appropriate, globally
Evidence of scalable business model (typically with a B2B focus) with a growing and predictable revenue stream
Company Specific Factors:
Sustainable competitive advantage
Competing on value rather than price; evidenced by increasing customer productivity
Use of Scale-Up Funds
Investments made by the Fund are targeted to support a Company’s organic growth and development.
Value is generated by growing the revenues, customer base and where necessary, recruiting suitably qualified employees.
We anticipate that money invested by the Fund is not used to solely fund preexisting working capital commitments.
Lead Investors & Board Representation
The Fund aims to invest in Qualifying Companies alongside a Lead Investor with sector specific skills. They will normally join the Investee’s Board as a directoror alternatively act as a Board Observer post-investment. Previous Newable EIS Funds have co-invested alongside industry leaders and successfully cashed out entrepreneurs with the experience to suggest that they can
add significant value to investees.
Scaling businesses need support; the Newable team aims to support portfolio companies in business development, H.R and future fundraising activities. We are able to potentially access resources including Office Space, Grant Writing and Export Advice provided by Newable.We can demonstrate a track record of helping companies obtain nondilutive Grant Funding as well as Coinvestment from both our Investor Network and Co-investment Partners. Operationally, we have helped portfolio companies to source new CEOs who are considered more suited to delivering the next stage of growth.
Managing the risks associated with early-stage investing sits at the heart of our Fund and we deploy various techniques to assess the core risks of each Company we invest in.
Diversification: Good ideas can fail. A primary goal of the Fund is to diversify away some firm-specific risk. We do this by investing in a portfolio of Qualifying Companies across a range of sectors.
Track record & cultural fit: Ultimately we are backing a Management Team to deliver a given business plan. We assess not only their track record and qualifications but also how well they will gel with our syndicate.
Commercial vs. Technical Risk: The fund targets investment where the majority of the risk relates to scaling operations and growing revenues.
We monitor the progress of portfolio companies post-investment. We speak with Company Management and Lead Investors to review performance against budget and strategic plans on a rolling six-month basis. Our Investment Agreements contain
provisions requiring portfolio companies to provide regular management information. Where possible, we will consult with a syndicate of Investors who may nominate one of their members as a Board Director/ Observer.
Venture Partner at Syncona Europe’s largest life science Fund and on the Board of Alan Turing Institute, UK data science and AI institute. Previously top rated Innovation Fund Manager in global equities for Abu Dhabi Investment Authority (ADIA) and New Star Asset Management. Degree in Chemistry, King’s College, London, MBA Cranfield and CFA Charterholder. Innovation fellow at Cambridge University.
Sanjeev started as an entrepreneur before going onto selling his own business. Prior to joining Newable, Sanjeev spent five year as a Wealth Manager specialising in venture capital. Sanjeev holds a diploma in Regulated Financial Planning and an MBA from CASS Business School.
Mike provides strategic financial support across the business and previously managed over £300m of VC investment funds. Mike has worked for some 30 years in financial services and qualified as a CA from PWC.
Company specific risks
All investments carry an inherent failure risk and some businesses are riskier than others. It is always possible that your investments may fail or be sold at a substantial loss. As a general rule, most early-stage knowledge intensive businesses raising investment under the EIS will typically have very little in the way of fixed assets. Most of their valuation is attributed to a combination of supporting IP (where possible) and the belief in the Management team to deliver the financial forecasts. EIS companies are often dependent on a few key executives. Any changes to the leadership team can have a big impact on the success of the company.
Tax reliefs are not guaranteed
The rates of tax, tax benefits and allowances that are described in this Information Memorandum are based on current legislation and HMRC practice - these may change from time to time and as such, they are not guaranteed and are subject to the personal circumstances of the investor.
Qualifying investments are not guaranteed
There is no guarantee that sufficient investments in EIS companies will be made within the expected timetable, or at all. In addition, it is possible that the EIS companies may subsequently cease to qualify for EIS tax reliefs, in which case, the tax reliefs you receive could be delayed or lost. Conflict of Interest Policy Newable or the Manager may have a material interest in any investment within the Fund. They may also have provided within the previous twelve months, significant advice in relation to the investment concerned or a related investment.
Diversification may not be achieved and investments may be in the same sector. As you will be investing in unquoted companies, the shares are illiquid and may be difficult or impossible to sell. It is therefore important to view the Fund as a medium to long-term investment of typically 5-8 years.
Investments made by the Fund are also at risk of dilution if the investee company issues more shares in future funding rounds. However, it should also be noted that the dilution effect can be offset by having cash in reserve and an increase in the valuation of these companies.
The past success of any EIS investment or its manager is not an indication of the likely future performance of the investment
you may be considering. There may be insufficient availability of quality investment opportunities for the fund manager.
Mitigating risk through portfolio diversification
Many investors lack the time or confidence to “pick a winner”, or a portfolio of winners. Many have recognised that by investing in a Fund, investors are able to diversify their risk through exposure to a wider portfolio of companies. This allows Investors to spread their cash across a select group of start-ups that meet our strict investment criteria. Investors still need to ensure they are
comfortable with the risk profile of a Fund investment and we would always recommend they engage suitable advisors to fully understand this.
The content above has been provided by Newable Ventures Limited who are authorised and regulated by the Financial Conduct Authority under firm registration number 843924.